Peritoneal GATA6+ macrophages function as a portal for Staphylococcus aureus dissemination.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 30 01 2019
accepted: 01 08 2019
pubmed: 24 9 2019
medline: 9 6 2020
entrez: 24 9 2019
Statut: ppublish

Résumé

Essentially all Staphylococcus aureus (S. aureus) bacteria that gain access to the circulation are plucked out of the bloodstream by the intravascular macrophages of the liver - the Kupffer cells. It is also thought that these bacteria are disseminated via the bloodstream to other organs. Our data show that S. aureus inside Kupffer cells grew and escaped across the mesothelium into the peritoneal cavity and immediately infected GATA-binding factor 6-positive (GATA6+) peritoneal cavity macrophages. These macrophages provided a haven for S. aureus, thereby delaying the neutrophilic response in the peritoneum by 48 hours and allowing dissemination to various peritoneal and retroperitoneal organs including the kidneys. In mice deficient in GATA6+ peritoneal macrophages, neutrophils infiltrated more robustly and reduced S. aureus dissemination. Antibiotics administered i.v. did not prevent dissemination into the peritoneum or to the kidneys, whereas peritoneal administration of vancomycin (particularly liposomal vancomycin with optimized intracellular penetrance capacity) reduced kidney infection and mortality, even when administered 24 hours after infection. These data indicate that GATA6+ macrophages within the peritoneal cavity are a conduit of dissemination for i.v. S. aureus, and changing the route of antibiotic delivery could provide a more effective treatment for patients with peritonitis-associated bacterial sepsis.

Identifiants

pubmed: 31545300
pii: 127286
doi: 10.1172/JCI127286
pmc: PMC6819137
doi:
pii:

Substances chimiques

GATA6 Transcription Factor 0
Gata6 protein, mouse 0
Vancomycin 6Q205EH1VU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4643-4656

Références

FASEB J. 2009 Oct;23(10):3393-404
pubmed: 19525403
Cell Host Microbe. 2018 Aug 8;24(2):271-284.e3
pubmed: 30033122
Ann Intern Med. 1966 Feb;64(2):328-40
pubmed: 5216294
Clin Drug Investig. 2018 Oct;38(10):935-943
pubmed: 30105549
Kidney Int. 2016 Oct;90(4):818-27
pubmed: 27528552
Blood. 2013 Jun 13;121(24):4930-7
pubmed: 23645836
Trends Immunol. 2015 Sep;36(9):547-55
pubmed: 26297103
Cell. 2018 Nov 29;175(6):1634-1650.e17
pubmed: 30433869
J Dig Dis. 2015 Jan;16(1):31-6
pubmed: 25385432
Nat Rev Microbiol. 2011 Mar;9(3):215-22
pubmed: 21297670
J Immunol. 2017 Mar 15;198(6):2352-2365
pubmed: 28167629
J Immunol. 2000 Apr 1;164(7):3713-22
pubmed: 10725730
Science. 2011 Oct 7;334(6052):101-5
pubmed: 21921158
J Immunol. 2005 Sep 15;175(6):3907-19
pubmed: 16148137
J Immunol. 2006 Dec 1;177(11):8154-63
pubmed: 17114491
J Exp Med. 2017 May 1;214(5):1281-1296
pubmed: 28432199
J Exp Med. 2016 Jun 27;213(7):1141-51
pubmed: 27325887
Pathogens. 2015 Nov 27;4(4):826-68
pubmed: 26633519
Nature. 2015 Nov 19;527(7578):323-8
pubmed: 26536114
Nat Immunol. 2010 Apr;11(4):295-302
pubmed: 20228796
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2568-73
pubmed: 20133793
Science. 2014 May 9;344(6184):645-648
pubmed: 24762537
Cell Host Microbe. 2016 Jul 13;20(1):99-106
pubmed: 27345697
Infect Immun. 2012 Oct;80(10):3721-32
pubmed: 22802349
Br J Pharmacol. 2002 Jul;136(5):645-58
pubmed: 12086974
Front Cell Infect Microbiol. 2012 Apr 24;2:43
pubmed: 22919634
Cell. 2016 Apr 21;165(3):668-78
pubmed: 27062926
Front Immunol. 2015 May 19;6:225
pubmed: 26042120
Front Microbiol. 2017 Jul 19;8:1354
pubmed: 28769913
J Antimicrob Chemother. 2012 Sep;67(9):2191-4
pubmed: 22661572
Nat Med. 2013 Jan;19(1):107-12
pubmed: 23242472
Dig Liver Dis. 2008 Aug;40(8):690-6
pubmed: 18337194
J Leukoc Biol. 1995 Mar;57(3):361-7
pubmed: 7884305
Am J Transplant. 2014 Nov;14(11):2640-4
pubmed: 25250641
EMBO Mol Med. 2011 Mar;3(3):129-41
pubmed: 21268281
J Exp Med. 1956 Jun 1;103(6):713-42
pubmed: 13319588
Nat Immunol. 2014 Jan;15(1):45-53
pubmed: 24270515
Clin Infect Dis. 2011 Apr 15;52(8):975-81
pubmed: 21460309
Br J Haematol. 2010 Nov;151(4):312-26
pubmed: 20813010
Transplantation. 2017 May;101(5):1013-1024
pubmed: 27495751
Cell. 2016 Aug 11;166(4):991-1003
pubmed: 27477514
Int J Antimicrob Agents. 2008 Nov;32 Suppl 1:S21-5
pubmed: 18757183
Lancet Infect Dis. 2011 Mar;11(3):208-22
pubmed: 21371655
Med Clin North Am. 2013 Jul;97(4):601-19, x
pubmed: 23809716
Cell. 2014 May 8;157(4):832-44
pubmed: 24792964
Int J Med Microbiol. 2018 Aug;308(6):607-624
pubmed: 29217333
J Immunol. 1996 Sep 15;157(6):2514-20
pubmed: 8805652
PLoS One. 2011;6(7):e22141
pubmed: 21799778

Auteurs

Selina K Jorch (SK)

Department of Physiology and Pharmacology, Immunology Research Group, and Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Bas Gj Surewaard (BG)

Department of Physiology and Pharmacology, Immunology Research Group, and Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Mokarram Hossain (M)

Department of Physiology and Pharmacology, Immunology Research Group, and Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Moritz Peiseler (M)

Department of Physiology and Pharmacology, Immunology Research Group, and Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Carsten Deppermann (C)

Department of Physiology and Pharmacology, Immunology Research Group, and Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Jennifer Deng (J)

Department of Physiology and Pharmacology, Immunology Research Group, and Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Ania Bogoslowski (A)

Department of Physiology and Pharmacology, Immunology Research Group, and Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Fardau van der Wal (F)

Department of Physiology and Pharmacology, Immunology Research Group, and Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Abdelwahab Omri (A)

Department of Chemistry and Biochemistry, Laurentian University, Sudbury, Ontario, Canada.

Michael J Hickey (MJ)

Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Melbourne, Victoria, Australia.

Paul Kubes (P)

Department of Physiology and Pharmacology, Immunology Research Group, and Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH